- Report
- July 2023
- 45 Pages
Global
From €610EUR$695USD£528GBP
- Report
- June 2021
- 110 Pages
Global
From €6139EUR$6,995USD£5,312GBP
- Report
- March 2024
- 147 Pages
Global
From €2984EUR$3,400USD£2,582GBP
€3730EUR$4,250USD£3,227GBP
- Report
- June 2025
- 250 Pages
India
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2024
- 140 Pages
Middle East, Africa
From €3396EUR$3,869USD£2,938GBP
- Report
- April 2024
- 140 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- November 2023
- 140 Pages
Global
From €3159EUR$3,599USD£2,733GBP
- Report
- July 2023
- 140 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- July 2023
- 140 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- May 2023
- 147 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- April 2023
- 147 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- January 2024
- 119 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- September 2023
- 116 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- July 2023
- 115 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- July 2023
- 220 Pages
Global
€4208EUR$4,795USD£3,641GBP
- Report
- July 2023
- 300 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- March 2023
- 255 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- December 2022
- 83 Pages
Global
From €3072EUR$3,500USD£2,658GBP
- Report
- December 2022
- 83 Pages
Global
From €3072EUR$3,500USD£2,658GBP
- Report
- November 2022
- 79 Pages
Global
From €1755EUR$2,000USD£1,519GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more